[
  {
    "ts": "2025-08-13T16:43:58+00:00",
    "headline": "Is it a Great Time to Invest in Danaher Corp. (DHR)?",
    "summary": "Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor letter. The full letter is available for download here. For the second quarter of 2025, the fund reported a net return of 7.24%, outperforming its benchmark, the Russell 1000 […]",
    "url": "https://finance.yahoo.com/news/great-time-invest-danaher-corp-164358704.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "b9fd1bb5-e708-3707-a545-a302c08ab595",
      "content": {
        "id": "b9fd1bb5-e708-3707-a545-a302c08ab595",
        "contentType": "STORY",
        "title": "Is it a Great Time to Invest in Danaher Corp. (DHR)?",
        "description": "",
        "summary": "Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor letter. The full letter is available for download here. For the second quarter of 2025, the fund reported a net return of 7.24%, outperforming its benchmark, the Russell 1000 […]",
        "pubDate": "2025-08-13T16:43:58Z",
        "displayTime": "2025-08-13T16:43:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4de858d44070a1d168359ecccfcc604b",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Danaher Corporation (DHR) Is \"Fool's Gold,\" Bemoans Jim Cramer",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GUGl..cccct8B.5GAQgZ9Q--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4de858d44070a1d168359ecccfcc604b.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jx.zT_h64bQMq1zS__HQvw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4de858d44070a1d168359ecccfcc604b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/great-time-invest-danaher-corp-164358704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/great-time-invest-danaher-corp-164358704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-13T14:11:00+00:00",
    "headline": "Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi",
    "summary": "The Saudi Arabia Clinical Chemistry Analyzer Market is set to reach US$ 249.11 million by 2033, growing from US$ 170.98 million in 2024 at a 4.27% CAGR. Market growth is fueled by government healthcare investments under Vision 2030, alongside rising chronic diseases and an aging population demanding precise diagnostics. Technological advancements in automation, AI integration, and point-of-care testing further enhance accessibility, especially in underserved areas. With increasing involvement fr",
    "url": "https://finance.yahoo.com/news/saudi-arabia-clinical-chemistry-analyzer-141100943.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c22193be-a58d-314f-9bbf-071266561555",
      "content": {
        "id": "c22193be-a58d-314f-9bbf-071266561555",
        "contentType": "STORY",
        "title": "Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi",
        "description": "",
        "summary": "The Saudi Arabia Clinical Chemistry Analyzer Market is set to reach US$ 249.11 million by 2033, growing from US$ 170.98 million in 2024 at a 4.27% CAGR. Market growth is fueled by government healthcare investments under Vision 2030, alongside rising chronic diseases and an aging population demanding precise diagnostics. Technological advancements in automation, AI integration, and point-of-care testing further enhance accessibility, especially in underserved areas. With increasing involvement fr",
        "pubDate": "2025-08-13T14:11:00Z",
        "displayTime": "2025-08-13T14:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/a39a29339cda0d4cbd41f7a59729bd60",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Saudi Arabian Clinical Chemistry Analyzer Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QbL8iDGFT.uoK.V25up7rA--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a39a29339cda0d4cbd41f7a59729bd60.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dxxC5hDnc_XT.QiJypxjPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a39a29339cda0d4cbd41f7a59729bd60.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/saudi-arabia-clinical-chemistry-analyzer-141100943.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/saudi-arabia-clinical-chemistry-analyzer-141100943.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "SIE.DE"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "6869.T"
            },
            {
              "symbol": "6501.T"
            },
            {
              "symbol": "SHL.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-13T12:41:00+00:00",
    "headline": "Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge",
    "summary": "The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investment in regenerative medicine and cell therapy, rising demand for cell-based vaccines and biologics, and technological advancements in cell culture efficiency. Mexico’s biopharmaceutical sector expansion, supported by enhanced bioprocessing infrastructure and strategic public-",
    "url": "https://finance.yahoo.com/news/mexico-microcarrier-market-trends-company-124100182.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "7c9b5335-e1b9-3b9a-b7b3-2ffda3ba2438",
      "content": {
        "id": "7c9b5335-e1b9-3b9a-b7b3-2ffda3ba2438",
        "contentType": "STORY",
        "title": "Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge",
        "description": "",
        "summary": "The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investment in regenerative medicine and cell therapy, rising demand for cell-based vaccines and biologics, and technological advancements in cell culture efficiency. Mexico’s biopharmaceutical sector expansion, supported by enhanced bioprocessing infrastructure and strategic public-",
        "pubDate": "2025-08-13T12:41:00Z",
        "displayTime": "2025-08-13T12:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/1a76bb9d7be9224a1c110c93a5abb4af",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Mexican Microcarrier Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0ioyikqkoWuMZKl4_KfREA--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/1a76bb9d7be9224a1c110c93a5abb4af.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jkBTy.P61kDzuLTnIR0AkA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/1a76bb9d7be9224a1c110c93a5abb4af.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mexico-microcarrier-market-trends-company-124100182.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mexico-microcarrier-market-trends-company-124100182.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "SRT.DE"
            },
            {
              "symbol": "BIO"
            },
            {
              "symbol": "GLW"
            },
            {
              "symbol": "LONN.SW"
            },
            {
              "symbol": "GETI-B.ST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-13T02:30:00+00:00",
    "headline": "[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision",
    "url": "https://finance.yahoo.com/news/latest-us-personalized-medicine-market-023000015.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "111b19cb-db59-3d93-937d-dc0f500108fa",
      "content": {
        "id": "111b19cb-db59-3d93-937d-dc0f500108fa",
        "contentType": "STORY",
        "title": "[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
        "description": "",
        "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision",
        "pubDate": "2025-08-13T02:30:00Z",
        "displayTime": "2025-08-13T02:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891",
          "originalWidth": 2514,
          "originalHeight": 1281,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2CrZC42kgw2SjdY2CY6ucw--~B/aD0xMjgxO3c9MjUxNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp",
              "width": 2514,
              "height": 1281,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/91DUI4_rVm8Et9pJYV6I4Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/latest-us-personalized-medicine-market-023000015.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/latest-us-personalized-medicine-market-023000015.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ILMN"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "EXAS"
            },
            {
              "symbol": "IBM"
            },
            {
              "symbol": "XGN"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]